MSH|^~\&|HIVE|RAX|LIMS|RJZ|20241013103300+0000||OML^O21^OML_O21|156bb6ab-15e7-42f3-a819-ecd16a5b4fbd|T|2.5.1|||ALPID|1||9737383230^^^NHS^NH~1234567^^^RPY^MR||London^Cersei||19731003|F|||2 Barclay Close^Fetcham^^^SE1 2AAPV1|1|I||||||||100^^|||||||||1001166717^^^RPY^VNORC|NW|160171601^RPY|||||||20230908000000+0000|||9999999998^^Hazel^^^Smith,|||||||||NOTFOUNDOBR|1|160171601^RPY||M119.5^Multi Target NGS Panel Small^England-GenomicTestDirectory||20230908000000+0000||||||||||9999999998^^Hazel^^^Smith,|||||||||||||||363358000^Malignant tumour of lung^SNM3NTE|1||Free text for diagnosis/reason for referral, transplant, life status at time of request details/ e.g. malignant tumour - molecular assessment will aid managementOBX|1|CE|128462008^Metastatic malignant neoplasm (disorder)^SNM3|||||||||||20230908000000+0000OBX|2|CE|6574001^Necrosis (morphologic abnormality)^SNM3|||||||||||20230908000000+0000SPM|1|RA257630||364611000000101^Tissue resection sample^SNM3|||||||||||||20230909110000+0000|||Y
